wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47861428-EBBBC1B0-776C-4D2A-BC47-825663D0EE75
Q47861428-EBBBC1B0-776C-4D2A-BC47-825663D0EE75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47861428-EBBBC1B0-776C-4D2A-BC47-825663D0EE75
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
P2860
Q47861428-EBBBC1B0-776C-4D2A-BC47-825663D0EE75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47861428-EBBBC1B0-776C-4D2A-BC47-825663D0EE75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8276aa58af6899eacfe5af23f1ce5e566bc0c9f8
P2860
Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy